Development and Validation of a Chronic Murine Lung Infection Model with P. aeruginosa

StatusActive
Effective start/end date18/04/1917/04/20

Funding

  • Janssen Pharmaceuticals: $168,250.00

Keywords

  • Infectious Diseases